Deep Medicine Acquisition Corp.
DMAQR
NASDAQ Global Market0.25
USD
-0.04
- -
CIK
0001857086
ISIN
US2437331109
CUSIP
243733110
Return %
Stock
S&P500
1Y
173.82
26.53
3Y
-26.47
76.60
5Y
-26.47
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Humphrey P. Polanen
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 595 Madison Avenue New York City NY United States of America 10017
- IPO Date
- Dec 2, 2021
- CIK
- 0001857086
- Similar Companies
- Business
- Deep Medicine Acquisition Corp. operates as a special purpose acquisition company (SPAC) primarily focused on identifying, acquiring, and growing businesses in the healthcare industry. Incorporated in 2020 and headquartered in New York, New York, the company originally intended to effect mergers, capital stock exchanges, asset acquisitions, stock purchases, reorganizations, or similar business combinations with healthcare-related enterprises. It does not have significant operations of its own but leverages strategic acquisitions to create value in the healthcare sector. The company's most recent major change occurred through a business combination with TruGolf, Inc., a company specializing in golf simulator software and hardware. This merger, completed in January 2024, resulted in TruGolf becoming a publicly traded entity under the name TruGolf Holdings, Inc. The transaction included an implied enterprise value of approximately $125 million and involved contingencies of up to $45 million for accelerating product development and expanding manufacturing in Salt Lake City. This marked a notable expansion into the consumer technology sector alongside its core healthcare focus, illustrating a strategic diversification move from a pure healthcare SPAC model to investments in consumer technology businesses as well. Deep Medicine Acquisition Corp. operates in the healthcare acquisition and consumer technology sectors through strategic mergers and acquisitions. It targets companies within North America primarily but has a focus on scalable businesses in healthcare and related technology industries. It is a subsidiary of Bright Vision Sponsor LLC and has demonstrated a recent strategic shift by integrating TruGolf's golf simulation hardware and software offerings into its portfolio while maintaining its presence in healthcare industry acquisitions. The company continues to explore further business combinations aligned with its growth strategy in healthcare and technology sectors.